pI: 8.6106 |
Length (AA): 311 |
MW (Da): 34759 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 9
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
7 | 298 | 5oge (A) | 22 | 331 | 23.00 | 0 | 0.59 | 1.17141 | 0.27 |
106 | 250 | 4he8 (H) | 18 | 258 | 34.00 | 0.78 | 0.45 | 0.409238 | 1.66 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127495)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G07290 | GDP-mannose transporter |
Arabidopsis thaliana | AT2G13650 | GDP-mannose transporter GONST1 |
Arabidopsis thaliana | AT4G32272 | nucleotide/sugar transporter family protein |
Arabidopsis thaliana | AT4G31600 | UDP-galactose transporter 7 |
Brugia malayi | Bm1_24080 | UDP-sugar transporter-like protein |
Candida albicans | CaO19.1232 | essential gene in C. albicans whose partial loss results in mannosylation and cell wall defects |
Candida albicans | CaO19.8817 | essential gene in C. albicans whose partial loss results in mannosylation and cell wall defects |
Caenorhabditis elegans | CELE_C52E12.3 | Protein SQV-7 |
Dictyostelium discoideum | DDB_G0278631 | DUF250 family protein |
Dictyostelium discoideum | DDB_G0276625 | hypothetical protein |
Drosophila melanogaster | Dmel_CG3874 | fringe connection |
Echinococcus granulosus | EgrG_000492100 | UDP glucuronic acid:UDP N acetylgalactosamine |
Echinococcus multilocularis | EmuJ_000492100 | UDP glucuronic acid:UDP N acetylgalactosamine |
Homo sapiens | ENSG00000130958 | solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 |
Homo sapiens | ENSG00000116704 | solute carrier family 35 (UDP-GlcA/UDP-GalNAc transporter), member D1 |
Leishmania braziliensis | LbrM.20.2700 | lipophosphoglycan biosynthetic protein (lpg2) |
Leishmania donovani | LdBPK_044290.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.34.4290 | lipophosphoglycan biosynthetic protein (lpg2) |
Leishmania major | LmjF.34.3120 | lipophosphoglycan biosynthetic protein (lpg2) |
Leishmania mexicana | LmxM.33.3120 | lipophosphoglycan biosynthetic protein (lpg2) |
Loa Loa (eye worm) | LOAG_01225 | hypothetical protein |
Mus musculus | 242585 | solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
Mus musculus | 102641304 | UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter-like |
Mus musculus | ENSMUSG00000033114 | solute carrier family 35, member D2 |
Oryza sativa | 4329973 | Os02g0614100 |
Oryza sativa | 4344457 | Os08g0107400 |
Saccharomyces cerevisiae | YGL225W | Vrg4p |
Saccharomyces cerevisiae | YER039C | Hvg1p |
Schistosoma japonicum | Sjp_0215980 | UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, putative |
Schistosoma mansoni | Smp_178490 | solute carrier family 35 member d1 |
Schmidtea mediterranea | mk4.000392.10 | UDP-sugar transporter sqv-7 |
Trypanosoma brucei gambiense | Tbg972.4.1520 | lipophosphoglycan biosynthetic protein 2, putative |
Trypanosoma brucei | Tb927.4.1640 | Nucleotide sugar transporter 3 |
Trypanosoma congolense | TcIL3000_4_1220 | lipophosphoglycan biosynthetic protein 2, putative |
Trypanosoma cruzi | TcCLB.506793.40 | UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, putative |
Trypanosoma cruzi | TcCLB.504057.120 | lipophosphoglycan biosynthetic protein 2, putative |
Trypanosoma cruzi | TcCLB.510611.20 | UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.1640 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.1640 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.1640 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.4.1640 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C52E12.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
YGL225W | Saccharomyces cerevisiae | inviable | yeastgenome |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.